The US Food and Drug Administration (FDA) is extending for 60 days the comment period for the draft Environmental Assessment and preliminary Finding of No Significant Impact linked to AquaBounty Technologies’ application for its genetically modified AquAdvantage salmon [...]
Want to keep reading?
Sign up for a trial to have access to our articles!
Have an account? Log in here:
Enter the email address associated with your account. We'll send you instructions to reset your password.
We’ve sent a link to to change your password.
Please check your inbox to reset your password securely and easily.